Press Release » Trang Công Nghệ | Trangcongnghe.vn

Ingredion Incorporated Reports Second Quarter 2026 Results

Globe Newswire

Ingredion Incorporated Reports Second Quarter 2026 Results

Globenewswire -

Press Release: Sanofi and Regeneron’s Dupixent approved in Japan as the first targeted medicine to treat adults with bullous pemphigoid

Globe Newswire

Press Release: Sanofi and Regeneron’s Dupixent approved in Japan as the first targeted medicine to treat adults with bullous pemphigoid

Globenewswire -

Ingredion Incorporated Reports 2025 Fourth Quarter and Full-Year Results

Globe Newswire

Ingredion Incorporated Reports 2025 Fourth Quarter and Full-Year Results

Globenewswire -

Motivair by Schneider Electric Announces New Range of CDUs to Meet the Rising Demands of HPC and AI Workloads

Globe Newswire

Motivair by Schneider Electric Announces New Range of CDUs to Meet the Rising Demands of HPC and AI Workloads

Globenewswire -

New Study Reveals $11.28M Annual Opportunity for Industrial Companies to Boost Competitiveness by Modernizing Closed Automation Systems

Globe Newswire

New Study Reveals $11.28M Annual Opportunity for Industrial Companies to Boost Competitiveness by Modernizing Closed Automation Systems

Globenewswire -

Ingredion Incorporated Reports Third Quarter 2025 Results

Globe Newswire

Ingredion Incorporated Reports Third Quarter 2025 Results

Globenewswire -

'We can build a future where energy is not just available, but intelligent' – Schneider Electric CEO unveils his vision for company’s future

Globe Newswire

'We can build a future where energy is not just available, but intelligent' – Schneider Electric CEO unveils his vision for company’s future

Globenewswire -

XEM THÊM TIN MỚI